Minimal Fallout for Life Science Firms from Japanese Quake, Analyst Says | GenomeWeb

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – The earthquake and tsunami that decimated parts of Japan last week may have some short- and mid-term negative effects for most life science tools and diagnostics firms, but longer-term softness from the disaster is not expected, according to an investment analyst.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: SNP reference panel from the Haplotype Reference Consortium, and more.

Halloran Consulting's Laurie Halloran lists at Stat News the mistakes she sees startup companies make when pursuing a clinical trial.

MIT researchers are using bees to collect and visualize urban microbiome samples, Wired reports.

Reliance on Excel leads to errors in gene name lists, a new Genome Biology paper reports.